BioMarin Pharmaceutical, Inc. (BMRN)

63.44 +1.61 (+2.60%) USD  |  NASDAQ  |  Feb 19, 16:00
63.44 0.00 (0.00%) After-Hours: 17:38
More

BioMarin Pharmaceutical EPS Diluted (TTM) : 2.669 for Sept. 30, 2025

EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Amicus Therapeutics, Inc. -0.0446
Gilead Sciences, Inc. 6.780
Merck & Co., Inc. 7.275
AbbVie, Inc. 2.367
Biogen, Inc. 8.806